Giới Hạn Vận Động Trong Bệnh Nhân IPF: Một Thử Nghiệm Ngẫu Nhiên Về Phục Hồi Phổi

King T, Pardo A, Selman M (2011) Idiopathic pulmonary fibrosis. Lancet 378:1949–1961 Christie J, Edwards L, Kucheryavaya A, Aurora P, Dobbels F, Kirk R, Rahmel A, Stehlik J, Hertz M (2010) The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart–lung transplantation report-2010. J Heart Lung Transplant 29:1103–1118 O’Donnell D, Laveneziana D (2007) Patterns of cardiopulmonary response to exercise in lung disease. Eur Respir Monogr 12:69–92 Jones N, Killian K (2000) Exercise limitation in health and disease. N Engl J Med 343:632–641 Shorr A, Wainright J, Cors C, Lettieri C, Nathan S (2007) Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 30:715–721 Jackson R, Ramos C, Glassberg M, Bejarano P, Gómez-Marin O (2010) Sildenafil therapy and exercise tolerance in idiopathic pulmonary fibrosis. Lung 188:115–123 Clanton T (2007) Hypoxia-induced reactive oxygen species formation in skeletal muscle. J Appl Physiol 102:2379–2388 Jackson R, Ramos C, Gupta C, Gómez-Marin O (2010) Exercise decreases plasma antioxidant capacity and increases urinary isoprostanes in IPF. Respir Med 104:1919–1928 Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O’Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T, ATS, ERS Pulmonary Rehabilitation Writing Committee (2006) American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 173:1390–1413 Holland A, Hill C (2008) Physical training for interstitial lung disease. Cochrane Database Syst Rev (4):CD006322. doi:10.1002/14651858.CD006322.pub2 Nishiyama O, Kondoh Y, Kimura T, Kato K, Kataoke K, Ogawa T, Watanabe F, Arizono S, Nishimura K, Taniguchi H (2008) Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 13:354–399 Salhi B, Troosters T, Behaegel M, Joos G, Derom E (2010) Effects of pulmonary rehabilitation in patients with restrictive lung diseases. Chest 137:273–279 Huppman P, Sczepansk B, Boensch M, Winterkamp Schonheit-Kenn U, Neurohr C, Behr J, Kenn K (2013) Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease. Eur Respir J 42:444–453 Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ, ATS, ERS, JRS, ALAT Committee on Idiopathic Pulmonary Fibrosis (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824 Arcasoy S, Christie J, Ferrari V, St. John Sutton M, Zisman D, Blumenthal N, Pochettino A, Kotloff R (2003) Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 167:735–740 Lynch D, Godwin D, Safrin S, Starko K, Hormel P, Brown K, Raghu G, King T, Bradford W, Schwartz D, Webb W (2005) High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 172:488–493 Rosdahl H, Gullstrand L, Salier-Eriksson J, Johansson P, Schantz P (2010) Evaluation of the Oxycon mobile metabolic system against the Douglas bag method. Eur J Appl Physiol 109:159–171 Puente-Maestu L, Sanz M, Sanz P, Ruiz de Ona J, Rodriguez-Hermosa J, Whipp B (2000) Effects of two types of training on pulmonary and cardiac responses to moderate exercise in patients with COPD. Eur Respir J 15:1026–1032 Puente-Maestu L, Sanz M, Sanz P, Cubillo J, Mayol J, Casaburi R (2000) Comparison of effects of supervised versus self-monitored training programmes in patients with chronic obstructive pulmonary disease. Eur Respir J 15:517–525 Palange P, Galassetti P, Mannix E, Farber M, Manfredi F, Serra P, Carlone S (1995) Oxygen effect on O2 deficit and VO2 kinetics during exercise in obstructive pulmonary disease. J Appl Physiol 78:2228–2234 Solberg G, Robstad B, Skjonsberg O, Borchsenius F (2005) Respiratory gas exchange indices for estimating the anaerobic threshold. J Sports Sci Med 4:29–36 American Thoracic Society/European Respiratory Society (2002) ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med 166:518–624 ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117 American Thoracic Society (1999) Dyspnea. Mechanisms, assessments and management: a consensus statement. Am J Resp Crit Care Med 159:321–340 Byrne N, Hills A, Hunter G, Weinsier R, Schutz Y (2005) Metabolic equivalent: one size does not fit all. J Appl Physiol 99:1112–1119 Haschke M, Zhang Y, Kahle C, Klawitter J, Korecka M, Shaw L, Christians U (2007) HPLC-atmospheric pressure chemical ionization MS/MS for quantification of 15-F2-isoprostane in human urine and plasma. Clin Chem 53:1–9 Klawitter J, Haschke M, Shokati T, Klawitter J, Christians U (2011) Quantification of 15-F2-isoprostane in human plasma and urine: Results from enzyme-linked immunoassay and liquid chromatography cannot be compared. Rapid Commun Mass Spectrom 25:463–468 Lundholm L, Mohme-Lundholm E, Vamos N (1963) Lactic acid assay with L(+) lactic acid dehydrogenase from rabbit muscle. Acta Physiol Scand 58:243–249 Elin R, Winter W (2004) Laboratory and clinical aspects of b-type natriuretic peptides. Arch Pathol Lab Med 128:669–697 Cnaan A, Laird N, Slasor P (1997) Using the general linear mixed model to analyze unbalanced repeated measures and longitudinal data. Stat Med 16:2349–2380 Powers S, Nelson W, Hudson M (2011) Exercise-induced oxidative stress in humans: causes and consequences. Free Radical Biol Med 51:942–950 Basu S (2008) F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications. Antioxid Redox Signal 10:1405–1434 Leuchte H, Neurohr C, Baumgartner R, Holzapfel M, Giehrl W, Vogeser M, Behr J (2004) Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 170:360–365 Blanco I, Ribas J, Xaubet A, Gómez F, Roca J, Rodriguez-Roisin R, Barberà J (2011) Effects of inhaled nitric oxide at rest and during exercise in idiopathic pulmonary fibrosis. J Appl Physiol 110:138–145 Henriksson J (1991) Effect of exercise on amino acid concentrations in skeletal muscle and plasma. J Exp Biol 160:149–165 Engelen M, Wouters E, Does J, Schols A (2001) Effects of exercise on amino acid metabolism in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161:859–864 Pisarenko O, Solomatina E, Ivanov V, Studneva I, Kapelko V, Smirnov V (1985) On the mechanism of enhanced ATP formation in hypoxic myocardium caused by glutamic acid. Basic Res Cardiol 80:126–134 Mitani Y, Maruyama K, Sakurai M (1997) Prolonged administration of l-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation 96:689–697 du Bois R, Weycker D, Albera C, Bradford W, Costabel U, Karteshev A, Lancaster L, Noble P, Sahn S, Swarcberg J, Thomer M, Veleye D, King T (2011) Six-minute-walk tests in idiopathic pulmonary fibrosis. Test validation and minimal clinically important difference. Am J Respir Crit Care Med 183:1231–1237 Bolton C, Bevan-Smith E, Blakely J, Crowe P, Elkin S, Garrod R, Greening N, Heslop K, Hull J, Man W, Morgan M, Proud D, Roberts M, Sewell L, Singh S, Walker P, Walmsley S (2013) British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax 68:ii1–ii30 Ferreira A, Garvey C, Connors G, Hilling L, Rigler J, Ferrell S, Cayou C, Shoriat C, Collard H (2009) Pulmonary rehabilitation in interstitial lung disease. Benefits and predictors of response. Chest 135:442–447 Cahalin L, Pappagianopoulus P, Prevost S, Wain J, Ginns L (1995) The relationship of the 6-minute walk test to maximal oxygen consumption in transplant candidates with end stage lung disease. Chest 108:452–459 Fell C, Liu L, Motika C, Kaserooni E, Gross B, Travis W, Colby T, Murray S, Toews G, Martinez F, Flaherty K (2009) The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179:402–407 Yorke J, Jones P, Swigris J (2010) Development and validity testing of an IPF specific version of the St George’s respiratory questionnaire. Thorax 65:921–926